LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Assayed Controls Introduced for HIV and Hepatitis Testing

By LabMedica International staff writers
Posted on 23 Dec 2009
New assayed controls, which include analytes for human immunodeficiency virus (HIV) and hepatitis testing, have been launched.

The Assayed Virotrol I controls are prepared from human serum and are analyzed in the same manner as patient samples. The ready-to-use liquid formulation of the controls eliminates potential reconstitution variability. Routine use of Assayed Virotrol I controls provides laboratories with the ability to monitor the performance of their test procedures and assure quality on an ongoing basis. Values for many of the popular test systems are provided with each lot of Assayed Virotrol I.

Bio-Rad (Hercules, CA, USA) introduced the assayed Virotrol I controls for HIV and hepatitis testing. Assayed Virotrol I controls were designed for use as assayed external quality controls with in vitro diagnostic assays for the determination of antibodies to HIV-1, antibodies to Hepatitis B core Antigen (anti-HBc), antibodies to Hepatitis C Virus (anti-HCV), and Hepatitis B Surface Antigen (HBsAg).

Assessments and comparisons can be performed using Assayed Virotrol products with the Unity Interlaboratory Program. Unity Real Time, a quality control data management software solution designed to improve the effectiveness of quality control processes, is also available.

Related Links:

Bio-Rad



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
Manual Pipetting Aid
Pipette Controllers macro

Latest Immunology News

Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
23 Dec 2009  |   Immunology

Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
23 Dec 2009  |   Immunology

Study Points to Autoimmune Pathway Behind Long COVID Symptoms
23 Dec 2009  |   Immunology



ADLM